[GlobeNewswire] - TEL AVIV, ISRAEL -- Alcobra Ltd. , an emerging biopharmaceutical company primarily focused on the development and commercialization of its proprietary drug, MG01CI (Metadoxine extended-release), to treat ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment